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Only few cases of primary renal Ewing’s sarcoma have been reported in the literature to date. We present here two cases of renal
ES/PNET with an uncanny presentation. The ﬁrst case was discovered after the patient presented clinically with irradiating ﬂank
pain, mimicking the pain related with kidney stones. The second case had clinical presentation of pulmonary thromboembolism
after the patient was involved in an automobilist accident. The tumors were mainly composed of small blue cells which by
immunohistochemical were positive for neural markers, and FISH revealed the translocation 22q12 for the EWSR1 gene. The
diagnosis of renal primitive neuroectodermal tumor/EWING tumor is very rare and usually involves several diﬀerent diagnostic
techniques. The diﬀerential diagnosis is usually broad with frequent overlapping features between the entities. The cases presented
in this paper illustrated the diﬃculties with which routine anatomical pathologist is faced when dealing with rare renal poorly
diﬀerentiated neoplasm in adults.
1.Introduction
Primitive neuroectodermal tumors (PNETs) are small,
round-cell tumors of neural crest origin classically found
in the central nervous system (CNS) but more recently
characterized in the periphery [1]. Peripherally located
PNETs(pPNETs)aremembersoftheEwing’ssarcomafamily
of tumors (EFTs). It is the second most common primary
tumor of bone in childhood. Less frequently it occurs in soft
tissues [1].
Ewing’s sarcoma/primitive neuroectodermal tumor
(ES/PNET) is an extraordinarily rare primary tumor in the
kidney. Only few cases of primary renal Ewing’s sarcoma
have been reported in the literature to date [1–7]. Renal
localization of pPNETs is found in young adults and is
characterized by an aggressive clinical course and poor
prognosis [1].
We present here two cases of Ewing’s sarcoma/primitive
neuroectodermal tumor occurring in two young women
with an unusual presentation. The diagnosis in both cases
was incidental during visits to the emergency room for other
health problems.
2.CaseReport
2.1.Case1. A32-year-oldfemalepresentedtotheemergency
room with right ﬂank pain that irradiates to the groin.
She was clinically diagnostic with kidney stones and indeed
a kidney stone was identiﬁed. However, the computed
tomography scan revealed a large right renal mass and right
ovarian cystic mass. The patient underwent a right-sided
laparoscopic radical nephrectomy along with an excision
of the ovarian cystic mass. Her postoperatively course was
uneventful except for some pain in the surgical incision site.
Grossly, an 11cm cyst adenoﬁbroma of the right fallopian
tube and ovary was identiﬁed. In addition, the kidney
showed an 8.3cm encapsulated tumor located at the pelvic2 Case Reports in Medicine
adipose tissue within the renal capsule (Figure 1(a)). Micro-
scopically, the tumor cells were arranged in solid sheets,
tightly packed cords, trabeculae with variable stroma, and
nests or ribbons of uniform small round blue cells with scant
cytoplasm,uniformnuclei,andstippledchromatin.Atplaces
rosettes were identiﬁed (Figure 1(b)). Mitotic activity was
present (Figure 1(c)). No necrosis was seen. Immunohisto-
chemical stains were performed on formalin-ﬁxed, paraﬃn-
embedded tissue using the usual avidin-biotin-peroxidase
complex method. The antibodies are listed in Table 1.T h e
tumor cells were strong positive for neuron-speciﬁc enolase
(Figure 1(d)), CD56 (Figure 1(e)), Cytokeratin AE1/3, and
Cam 5.2. Weakly positive stain for PGP9.5, bcl2, and CD99
was identiﬁed. The tumor was negative for synaptophysin,
EMA, inhibin, chromogranin, vimentin, WT1, S100, CK7,
estrogen receptor, androgen receptor, CD10, and Carbonic
anhydrase 9. Ki 67 showed a high proliferation rate index of
30% (Figure 1(f)). Fluorescent in situ hybridization analysis
using the 22q12 LSI, EWSR1, Dual-Color Break-Apart Probe
was performed on fresh tissue and showed 18 (29.5%) of
the cells with the translocation pattern 22q12 for the EWSR1
gene.Thehistomorphological,immunohistochemicalproﬁle
and FISH results were consisted with a renal primitive neu-
roectodermal tumor/EWING tumor. The patient underwent
chemotherapy and the followup 2 years after the diagnosis
s h o w e dn oe v i d e n c eo ft u m o r .
2.2.Case2. A21-year-oldfemalepresentedtotheemergency
room with a left foot fracture, nasal fracture, and loss
of her pregnancy caused by a motor vehicle accident. A
month later, the patient returned to the emergency room
with complaints of shortness of breath, icterus, and dark
urine. A chest-computed tomography scan revealed pul-
monary embolism. She underwent a pulmonary embolism
protocol which included a computed tomography of the
chest, abdomen, and pelvis. The exam showed extensive
central bilateral pulmonary embolism and a large right
atrial thrombus in continuity with thrombotic material
within the inferior vena cava. In addition, her right kidney
had poorly contrast-enhancing raising the possibility of a
right renal vein thrombosis extending into the right atrium
with subsequent pulmonary embolism. She underwent a
pulmonary tumor embolectomy, right atrial mass removal,
and tumor embolectomy thrombectomy of the hepatic
inferior vena cava as well as placement of an inferior
vena cava ﬁlter. The patient underwent a sternotomy with
cardiopulmonary bypass. She started chemotherapy with
etoposide and ifosfamide combination therapy. The tumor
invaded the renal vein and extended to the resection margin.
The histological examination of the right atrial, pulmonary
artery, and caval vein thrombus revealed islands of uniform
small round blue cells with scant cytoplasm, uniform nuclei,
and stippled chromatin intermixed with necrosis and blood
clot (Figure 2(b)). The viable tumor cells showed brisk
mitosis. Immunohistochemical stains were performed on
formalin-ﬁxed, paraﬃn-embedded tissue using the usual
avidin-biotin-peroxidase complex method. The antibodies
are listed in Table 1. The viable tumor cells showed a
strong membranous stains for CD99 (Figure 2(c)), focal
membranous and cytoplasm stain for CD56 (Figure 2(d)), a
cytoplasm dot pattern for synapthophysin (Figure 2(e)), and
focal cytoplasm and membranous stain for PGP9.5, BCL2,
and vimentin. The lymphoid cells in the background were
positive for LCA and CD43. The tumor cells are negative
forCD3,CD20, CD30,alpha-fetoprotein,betahumanchori-
onic gonadotrophin, pan-cytokeratin, CAM5.2, myogenin,
epithelial membrane antigen, thyroid transcription factor-
1, CK20, desmin, smooth muscle actin, HMB45, S100, and
WT1.Fivemonthslater,thepatienthadarightnephrectomy.
Grossly, the right kidney revealed multifocal tan-brown to
yellow masses in the upper and lower poles ranging from 0.4
× 0.4cm to 4.3 × 2.8cm (Figure 2(a)). Fluorescent in situ
hybridization analysis using the 22q12 LSI, EWSR1, Dual-
Color Break-Apart Probe was performed on fresh tissue
and showed 57 (95.0%) of the cells with the translocation
pattern 22q12 for the EWSR1 gene (Figure 2(f)). In addition
a FISH for the X-18 SYT translocation was performed
but it was negative. The histomorphological, immunohis-
tochemical proﬁle and FISH results were consisted with a
renal primitive neuroectodermal tumor/EWING tumor. The
patient completed her 12 months of chemotherapy and the
one-year followup revealed no evidence of tumor.
3. Discussion
The diagnosis of renal primitive neuroectodermal tumor/
EWING tumor is very rare and usually involves several
diﬀerent diagnostic techniques. The most challenging part is
the diﬀerential diagnosis which is broad with morphological
and immunohistochemical overlapping features between
the entities. Therefore, mostly frequently molecular biology
techniques need to be applied for a deﬁnitive diagnosis.
We reported 2 cases of renal primitive neuroectodermal
tumor/EWING tumor with an unusual clinical presentation
which were incidentally found during imaging. These cases
illustrated very well the diﬃculties with which general
pathologists are faced in the routine anatomical pathology
examination when faced with renal poorly diﬀerentiated
neoplasm in adults.
Both cases had an uncanny presentation. In case number
1, the 8.3cm kidney mass was discovered after the patient
presented clinically with irradiating ﬂank pain, mimicking
the pain related with kidney stones. Moreover, it was
associated with a benign ovarian tumor and the diagnosis
of renal primitive neuroectodermal tumor/EWING was only
possibleafterextensiveimmunohistochemicalandmolecular
studies, which were mainly performed to rule out other
entities that were considered due to the unusual presen-
tation and associated ovarian tumor. In literature-reported
renal primitive neuroectodermal tumor/EWING, the clinical
presentation was often nonspeciﬁc, comprising abdominal
pain, palpable mass, and hematuria, and most reported
cases were diagnosed incidentally by image studies [1, 4–
8]. Few tumors had associated concurrent abnormalities
such as hemangioma, central nervous system primitive
neuroectodermal tumor, and ovarian disgerminoma [1].Case Reports in Medicine 3
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Figure 1:Thirty-two-year-oldpatient,right-sidedlaparoscopicradicalnephrectomy.(a)Grosspictureoftherightkidneyshowingan8.3cm
encapsulated tumor located at the pelvic adipose tissue within the renal capsule. (b) Microscopic photography of the tumor showing tumor
cells arranged in solid sheets, tightly packed cords, and trabeculae with variable stroma. Tubular structures (arrow) can be identiﬁed in the
periphery of the cell nests (HE ×20). (c) High power view of the tumor cells showing uniform small round blue cells with scant cytoplasm,
uniform nuclei, and stippled chromatin. Mitotic activity (arrow) was present (HE ×100, oil). (d) The tumor cells were strongly positive
for NSE in a cytoplasmic stain (DAB X50). (e) Strong membranous and cytoplasmic stain for CD56 (DAB X50). (f) Ki 67 shows a high
proliferation rate index of 30% (DAB X50).
Oursecondcasereportwasevenmoreunusual.TheCase
2 presented with respiratory problems after being involved
in an automobilistic accident where multiple fractures were
acquired. The clinical presentation suggested pulmonary
thormboembolism,whichwasconﬁrmedbyimage;however,
after histopathological examination of the thrombectomy
material small blue cell tumor of uncertain origin was
regarded as the cause for the extensive thromboembolic
event. Later on, a nephrectomy was performed and a renal
primitive neuroectodermal tumor/EWING was diagnosed.
As far as literature reports, there are few reports of
renal primitive neuroectodermal tumor/EWING with tumor
thrombus extending to the inferior vena cava [9, 10].
However, in our case the thrombus extended all the way4 Case Reports in Medicine
Table 1: Speciﬁcations of the antibodies used in the study.
Antibody Clone Company Dilution Retrieval
NSE O10 Immunotech (France) PD CC1 mild 30”
CD56 7 Vector (US) 1/10 CC1 mild 30”
CKAE1/3 PGM-1 DAKO (Denmark) 1/100 CC1 mild 30”
Cam 5.2 KP-1 VENTANA (USA) PD CC1 mild 30”
PGP9.5 10D6 VECTOR (UK) 1/250 CC1 mild 30”
Bcl2 Polyclonal NOVACASTRA (UK), 1/500 None
CD99 12D6 VECTOR (UK) 1/100 CC1 mild 30”
Synaptophysin Polyclonal GENETEX, Inc. (USA) 1/25 Protease digestion 4”
EMA 55K-2 DAKO (Denmark) 1/500 CC1 mild 30”
Ki67 MIB-1 DAKO (Denmark) 1/25 CC1 mild 30”
Inhibin RI’ DAKO (Denmark) 1:50 CC1 standard 60”
Chromogranin LK2H10 VENTAN (USA) PD None
Vimentin V9 VENTANA (USA) PD CC1 standard 60”
WT1 6F-H2 DAKO (Denmark) 1:25 CC1 standard 60”
S100 Polyclonal DAKO (Denmark) 1:500 CC1 short 8”
CK7 DAKO (Denmark) 1:200 Protease 24”
ER SP1 VENTANA (USA) PD CC1 standard 60”
Pan-CK ABCAM (USA) 1:100 CC1 mild 30”
CAM5.2 CAM5.2 Beckton-Dickison (USA) 1:10 Protease 18”
Myogenin VENTANA (USA) PD CC1 standard 60”
TTF1 B72.3 BIOGENEX (USA) 1:50 CC1 mild 30”
CK20 K5208 DAKO (Denmark) 1:50 CC1 mild 30”
BHCG VENTANA PD CC1 mild 30”
AFP Polyclonal DAKO (Denmark) 1:2000 CC1 standard 60”
CD30 BER-H2 VENTANA (USA) PD CC1 standard 60”
CD20 L26 VENTANA (USA) PD CC1 mild 30”
CD3 Polyclonal DAKO (Denmark) 1:100 CC1 mild 30”
CD43 L60 VENTANA (USA) PD CC1 short 8”
LCA RP2/18 VENTANA (USA) PD CC1 mild 30”
CA9 Polyclonal NOVUS BIOLOGICALS (USA) 1:1000 CC1 mild 30”
CD10 CELL MARQUE (USA) PD CC1 standard 60”
AR AR441 DAKO (Denmark) 1:100 CC1 standard 60”
Desmin DE-R-11 VENTANA (USA) PD CC1 mild 30”
SMA IA4 VENTANA (USA) PD None
HMB45 CMA710 CELL MARQUE (USA) PD CC1 mild 30”
CC1: Cell Conditioning 1 is antigen retrieval from Ventana Benchmark similar to high pH EDTA buﬀer. PD: prediluted, CA9: carbonic anhydrase 9, SMA:
smooth muscle actin, AR: Androgen receptor, AFP: alpha-fetoprotein, TTF1: thyroid transcription factor-1, ER: estrogen receptor, and NSE: neuron-speciﬁc
enolase.
up to the inferior vena cava, right atrium, and bilateral
pulmonary arteries, with more aggressive tumor extension
than the previous reported cases [9, 10].
As far as disease progression, our cases had a better
response to chemotherapy and surgery than the previ-
ous reported cases of renal primitive neuroectodermal
tumor/EWING [1]. The outcome of other patients reported
in the literature included very short survival, nonresponse to
intensive therapy, and death 5 months after diagnosis [1, 4–
8, 11]. Both our cases were free of disease after one year, and
long-term outcome is still awaited.
Renal primitive neuroectodermal tumor/EWING tumor
should be diﬀerentiated from other small blue cell tumors
arising in the kidney such as blastemal predominant Wilms
tumor, neuroblastoma, rhabdomyosarcoma, lymphoblastic
lymphoma, small cell neuroendocrine carcinoma, desmo-
plastic small blue cell tumor, and synovial sarcoma [1,
12]. All of them have very similar morphology with fre-
quent overlapping morphological features, thus, extensive
immunohistochemistry panel, in addition to the morpho-
logical features, is essential in reaching the ﬁnal diagnosis
[1, 12].
CD99 was the former marker for Ewings’ sarcoma;
however, it is also expressed in other tumors such as
synovial sarcoma, Wilms’ tumor, vascular malignancy, neu-
roendocrine tumors, and lymphoblastic lymphoma, andCase Reports in Medicine 5
(a) (b)
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(e)
EWS/22q12
(f)
Figure 2: Twenty-one-year-old female. (a) Bivalved right kidney: gross photography showing islands of tan tissue with hemorrhage and
necrotic yellow friable areas (center). (b) Microphotography of the right atrial mass removed from the patient showing islands of small blue
cells intermixed with necrotic material and blood. (c) The tumor cells showed positive membranous satins for CD99 (DAB X40). (d) Viable
tumor cells positive for CD56, note that the necrotic cells are negative (DAB X40). (e) Synapthophysin was positive in the viable neoplastic
cells in a cytoplasm dot-like pattern (DAB X40). (f) Fluorescent microphotography: normal cell lacking t(22; q12), a 2-fusion signal pattern
is expected to be seen, reﬂecting the 2 intact copies of EWSR1. In abnormal cell (circle) with t(22; q12), a 1-fusion, 1 green, 1 orange signal
pattern will be expected to occur. This conﬁrmed the EWSR1 fusion transcripts in this peripheral primitive neuroectodermal tumor of the
kidney.
therefore nowadays is not considered a reliable marker of
tumor origin [1, 7, 8]. Our presented ﬁrst case showed a
very weak stain for CD99, and the second one because of the
bloody background was very diﬃcult to interpret illustrating
some of the diﬃculties in using this marker in diagnostic
grounds.
From the neuroendocrine marker, CD56 was positive in
both cases whereas synapthophysin was positive only in the
secondcaseinacytoplasmdotpattern.Thispatternhasbeen
considered as an unspeciﬁc pattern, but a recent publication
described the pattern in oligodendrogliomas, and therefore
the pattern seems to indicate neural origin [13].
The features favoring the diagnosis of blastemal Wilms
tumor are young age and positivity of blastemal elements
for vimentin, low molecular weight cytokeratin, epithelial
membrane antigen, and WT1. Both cases in our study were6 Case Reports in Medicine
positive for cytokeratin and vimentin. However, WT1 was
negative and EWSR1 gene was identiﬁed by FISH, and
therefore adult Wilms’ tumor was ruled out.
Renal neuroblastomas are also similar morphologically
to renal primitive neuroectodermal tumor/EWING tumor.
However, they usually occur at the age of 5 years and
show a ﬁbrillary background or a ganglionic diﬀerentiation
facilitating the diagnosis. Immunohistochemistry is very
useful to diﬀerentiate it from renal primitive neuroecto-
dermal tumor/EWING tumor because neuroblastomas are
consistently positive for NSE and chromogranin and mostly
negative for CD99.
Rhabdomyosarcoma is often positive for smooth muscle
actin, desmin, and myogenin; all of them were negative in
our patients. Desmoplastic small blue cell tumors are also
positive for desmin, and synovial sarcoma was ruled out
using the FISH for the X-18 SYT translocation, which was
negative.
F i n a l l y ,l y m p h o b l a s t i cl y m p h o m ac o u l db ee x c l u d e db y
performing analysis with LCA and other hematopoietic
markers; however, in the second case the background was
positive for lymphoid markers. The diﬀerential was per-
formedbymorphology ofthetumorcellswhichhadstippled
chromatin and pleomorphism whereas the lymphoid cells
formed a uniform monotonous population with small dark
nuclei in the background.
In our cases, the molecular analysis identifying the
translocation was a supportive and strong conﬁrmatory tool,
especially with the confusing immunohistochemical proﬁle.
Fluorescent in situ hybridization analysis using the 22q12
LSI, EWSR1, and Dual-Color Break-Apart Probe showed
the translocation pattern 22q12 for the EWSR1 gene. The
probe used in our cases is from Vysis (Abbott Laboratories,
Downers Grove, Ill, USA) and is commercially available, and
data have been published using this probe. The probe is an
EWSR1 (22; q12) Dual-Color, Break-Apart Rearrangement
Probe, which consists of a mixture of 2 FISH DNA probes.
The ﬁrst is a 500kb probe labeled in spectrum orange and
ﬂanks the 5V side of EWSR1 gene and extends inward into
intron 4. The second probe is 1100kb labeled in spectrum
green and ﬂanks the 3V side of the EWSR1 gene. There is
7-kb probe between the 2 probes. The known breakpoints
within the EWSR1 gene are restricted to introns 7 through
10V. Approximately 90% of the translocations involving
EWSR1 gene result in t(11; 22) translocation characteristic
of EWS/PNET.
Because most renal primitive neuroectodermal tumors
/EWING tumor of the kidney are poorly diﬀerentiated and
haveabroadmorphologicalspectrum,itisimportanttohave
genetic conﬁrmation for the presence of t(11; 22) for the
accurate identiﬁcation of these tumors, and the FISH probe
is a good and easy method to do so.
In summary, we report two cases of primitive neu-
roectodermal tumor/EWING tumor arising in the kid-
ney conﬁrmed by morphology, immunohistochemistry and
FISH. The unusual presentation in our cases delayed the
diagnosis, being both tumors diagnosed incidentally. Thus,
we believe that these cases added some features to the already
broad spectrum of presentations described in renal primitive
neuroectodermal tumor/EWING tumor and also showed the
importance of molecular analysis together with morpholog-
ical and immunohistochemical features for conﬁrmation of
this poorly diﬀerentiated neoplasm.
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